Review Article
Volume 16 Issue 3 - 2021
Psoriasis and Nutritional Therapy
Egidi Gabriele1*, Teleman Adele Anna1, Velluti Valeria1, Gagliardi Lucilla1, Anselmi Gaia1, Leone Sabrina1, Frangella Silvia2 and Miggiano Giacinto1
1UOC di Nutrizione Clinica, Area Medicina Interna, Gastroenterologia e Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A, Gemelli IRCCS Università Cattolica del Sacro Cuore, Rome, Italy
2Sezione di Medicina Genomica, Dipartimento Scienze della Vita e Sanità Pubblica, Facoltà di Medicina e Chirurgia, Università Cattolica Sacro Cuore, Roma, Italy
*Corresponding Author: Egidi Gabriele, UOC di Nutrizione Clinica, Area Medicina Interna, Gastroenterologia e Oncologia Medica, Dipartimento di Scienze Gastroenterologiche, Endocrino Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario A, Gemelli IRCCS Università Cattolica del Sacro Cuore, Rome, Italy.
Received: November 09, 2020; Published: February 27, 2021


The role of nutrition in the treatment of psoriasis has been studied for many years. Recently, comorbidity conditions have been associated with psoriasis. Such observation has fostered an interest in nutrition to improve comorbidity conditions. Many studies have evaluated the role of nutrients in the development of psoriasis. However, few studies have investigated the effect of a healthy diet, such as the Mediterranean one.

The purpose of this study is, to investigate the relationship between adherence to the Mediterranean diet, along with a healthy lifestyle, and the severity of psoriasis.

Keywords: Psoriasis; Mediterranean Diet; Healthy Lifestyle; Nutrients; Nutrition


  1. Coimbra S., et al. “Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy”. British Journal of Dermatology 6 (2010): 1282-1290.
  2. Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2010: Results by Cause1990–2010”. Seattle: IHME (2012).
  3. Parisi R., et al. “Identification and Management of Psoriasis and Associated Comorbidity (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence”. Journal of Investigative Dermatology 2 (2013): 377-385.
  4. Mrowietz U., et al. “Psoriasis: To treat or to manage?” Experimental Dermatology 10 (2014): 705-709.
  5. Cainelli T., et al. “Manuale di Dermatologia medica e chirurgica” (2017).
  6. Baliwag J., et al. “Cytokines in psoriasis”. Cytokine 73 (2015): 342-350.
  7. Capon F. “The genetic basis of psoriasis”. International Journal of Molecular Sciences 18 (2017): 2526.
  8. Afifi L., et al. “Dietary behaviors in psoriasis: patient-reported outcomes from a U.S. National Survey”. Dermatology and Therapy 7 (2017): 227-242.
  9. Christophers E. “Comorbidities in psoriasis”. Clinics in Dermatology 25 (2007): 529-534.
  10. Shahw an KT and Kimb all AB. “Psoriasis and cardiovascular disease”. Medical Clinics of North America 99 (2015): 1227-1242.
  11. Griffiths CE M and Barker JNWN. “Pathogenesis and clinical features of psoriasis”. Lancet 370 (2007): 263-227.
  12. Reich K. “The concept of psoriasis as a systemic inflammation: implications for disease management”. The Journal of the European Academy of Dermatology and Venereology 26 (2012): 3-11.
  13. Wang L., et al. “Acupuncture for psoriasis: protocol for a systematic review”. BMJ Open 5 (2015): e007526.
  14. Harari M., et al. “Clinical evaluation of a more rapid and sensitive psoriasis assessment severity score (PASS), and its comparison with the classic method of psoriasis area and severity index (PASI), before and after climatotherapy at the Dead-Sea”. International Journal of Dermatology 39 (2000): 913-918.
  15. Dubertret L., et al. “European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey”. British Journal of Dermatology 4 (2006): 729-736.
  16. Korman NJ., et al. “Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA”. Clinical and Experimental Dermatology 41 (2016): 514-521.
  17. Wu JJ., et al. “The association of psoriasis with autoimmune diseases”. Journal of the American Academy of Dermatology (2012).
  18. A Pona., et al. “Diet and psoriasis. Review”. Dermatology Online Journal 2 (2019).
  19. P Ungprasert., et al. “Psoriasis and risk of celiac disease: a systematic review and meta-analysis”. Indian Journal of Dermatology 1 (2017): 41-46.
  20. Bhatia BK., et al. “Diet and Psoriasis: Part 2. Celiac Disease and Role of a Gluten-Free Diet”. Journal of the American Academy of Dermatology 2 (2014): 350-358.
  21. Ojetti V., et al. “High prevalence of celiac disease in psoriasis”. The American Journal of Gastroenterology 98 (2003): 2574-2575.
  22. Birkenfeld S., et al. “Coeliac disease associated with psoriasis”. British Journal of Dermatology 161 (2009): 1331-1334.
  23. Makredes M., et al. “The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis”. Journal of the American Academy of Dermatology 61 (2009): 405-410.
  24. Davidson A and Diamond B. “Autoimmune diseases”. The New England Journal of Medicine 345 (2001): 340-350.
  25. Cotsapas C., et al. “Pervasive sharing of genetic effects in autoimmune disease”. PLOS Genetics7 (2011): e1002254.
  26. Counsell CE., et al. “Coeliac disease and autoimmune thyroid disease”. Gut 35 (1994): 844-846.
  27. Schuppan D and Hahn EG. “Celiac disease and its link to type 1 diabetes mellitus”. Journal of Pediatric Endocrinology and Metabolism 1 (2001): 597-605.
  28. Smyth DJ., et al. “Shared and distinct genetic variants in type 1 diabetes and celiac disease”. The New England Journal of Medicine 359 (2008): 2767-2777.
  29. Ventura A., et al. “Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP study group for autoimmune disorders in celiac disease”. Gastroenterology 117 (1999): 297-303.
  30. Woo WK., et al. “Coeliac disease-associated antibodies correlate with psoriasis activity”. British Journal of Dermatology 151 (2004): 891-894.
  31. Lindqvist U., et al. “IgA antibodies to gliadin and coeliac disease in psoriatic arthritis”. Rheumatology 41 (2002): 31-37.
  32. Ludovico Abenavoli., et al. “Steven Paul Nisticò The Skin in Celiac Disease Patients: The Other Side of the Coin Medicina 55.9 (2019): 578.
  33. Michaëlsson G., et al. “Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet”. British Journal of Dermatology 142 (2000): 44-51.
  34. Chalmers RJ and Kirby B. “Gluten and psoriasis”. British Journal of Dermatology 142 (2000): 5-7.
  35. Bhavnit K Bhatia., et al. “Diet and Psoriasis: Part 2. Celiac Disease and Role of a Gluten-Free Diet”. Journal of the American Academy of Dermatology 2 (2014): 350-358.
  36. S Pitukweerakul., et al. “Hypovitaminosis D is Associated with Psoriasis: A Systematic Review and MetaAnalysis”. Kansas Journal of Medicine 4 (2019): 103-108.
  37. Mattozzi C., et al. “Psoriasis, vitamin D and the importance of the cutaneous barrier’s integrity: An update”. British Journal of Dermatology 5 (2016): 507-514.
  38. Wareeporn D., et al. “The Clinical Effect of Oral Vitamin D2 Supplementation on Psoriasis: A Double-Blind, Randomized, Placebo-Controlled Study. Clinical Study”. Hindawi Dermatology Research and Practice (2019): 9.
  39. Talbott W and Duffy N. “Complementary and alternative medicine for psoriasis: what the dermatologist needs to know”. American Journal of Clinical Dermatology 16 (2015): 147-165.
  40. Millsop JW., et al. “Diet and psoriasis, part III: role of nutritional supplements”. Journal of the American Academy of Dermatology 71 (2014): 561-569.
  41. Maurice PD., et al. “The effects of dietary supplementation with fish oil in patients with psoriasis”. British Journal of Dermatology 5 (1987): 599-606.
  42. Ziboh VA., et al. “Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects”. Archives of Dermatology 11 (1986): 1277-1282.
  43. Shih-Jyun Y and Ching-Chi C. “Effects of fish oil supplement on psoriasis: a meta-analysis of randomized controlled trials. Research article”. BMC Complementary and Alternative Medicine 19 (2019): 354.
  44. Kharaeva Z., et al. “Clinical and biochemical effects of Coenzima Q10, vitamin E, and selenium supplementation to psoriasis patients”. Nutrition 25 (2009): 295-302.
  45. Yousefzadeh H., et al. “Investigation of dietary supplements prevalence as complementary therapy: comparison between hospitalized psoriasis patients and non-psoriasis patients, correlation with disease severity and quality of life”. Complementary Therapies in Medicine 33 (2017): 65-71.
  46. Smith N., et al. “Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature”. Journal of the American Academy of Dermatology 61 (2009): 841-856.
  47. Naldi L., et al. “Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project”. Dermatology4 (2008): 365-373.
  48. Sakai R., et al. “Prognostic factor analysis for plaque psoriasis”. Dermatology2 (2005): 103-106.
  49. Herron MD., et al. “Impact of obesity and smoking on psoriasis presentation and management”. Archives of Dermatology 12 (2005): 1527-1534.
  50. Naldi L., et al. “Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study”. Journal of Investigative Dermatology 1 (2005): 61-67.
  51. Coimbra S., et al. “The triad psoriasis-obesity-adipokine profile”. The Journal of the European Academy of Dermatology and Venereology 11 (2016): 1876-1885.
  52. Sterry W., et al. “International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review”. British Journal of Dermatology 4 (2007): 649-655.
  53. Saumya Choudhary., et al. “The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study”. Endocrine, Metabolic and Immune Disorders - Drug Targets (2019).
  54. B Kimball., et al. “Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis”. The American Journal of Medicine 4 (2010): 350-357.
  55. Raychaudhuri SK., et al. “Diagnosis and classification of psoriasis”. Autoimmunity Reviews S1568-9972 14 (2014): 00020-2.
  56. Armstrong AW., et al. “Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis”. JAMA Dermatology 1 (2013): 84-91.
  57. Muacevic A and John R Adler. “Effects of Weight Loss on Psoriasis: A Review of Clinical Trials. Cureus. 2018”. British Journal of Dermatology 4 (2007): 649-655.
  58. D Yan., et al. “The Role of the Skin and Gut Microbiome in Psoriatic Disease. Author manuscript”. Current Dermatology Reports 2 (2017): 94-103.
  59. FM Codoñer., et al. “Gut microbial composition in patients with psoriasis”. Scientific Reports 8 (2018): 3812.
  60. Takemoto A., et al. “Molecular characterization of the skin fungal microbiome in patients with psoriasis”. British Journal of Dermatology 2 (2015): 166-170.
  61. Paulino LC., et al. “Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions”. Journal of Clinical Microbiology 8 (2006): 2933-2941.
  62. Paulino LC., et al. “Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR”. FEMS Yeast Research 3 (2008): 460-471.
  63. Phan C., et al. “Association between Mediterrean Anti-Infiammatory Dietary Profile and Severity of Psoriasis”. JAMA Dermatology 9 (2018): 1017-1024.
  64. Adam R Ford BS., et al. “Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation. A Systematic Review”. JAMA Dermatology 8 (2018): 934-950.
  65. Sijia Wang., et al. “Recent advances on the roles of epidermal growth factor receptor in psoriasis”. American Journal of Translational Research 2 (2019): 520-528.
  66. El-Komy M., et al. “Insulin-like growth factor-1 in psoriatic plaques with PUVA and methotrexate”. The Journal of the European Academy of Dermatology and Venereology 11 (2011): 1288-1294.
  67. CA Elmets., et al. “Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities 80.4 (2019): 1073-1113.
Citation: Egidi Gabriele., et al. “Psoriasis and Nutritional Therapy”. EC Nutrition 16.3 (2021): 66-75.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 21, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to